YouMed

Versione italiana

last video

What is needed to win the battle against cancer

Prof. Franco Cavalli
Scientific Director, Oncology Institute of Southern Switzerland, S. Giovanni Hospital Bellinzona, CH

Can the battle against cancer be lost? From a diagnostic and therapeutic point of view, the progress made in recent years has been irrefutable. The outlook is less rosy when considering the global mortality rate, in the light of the distribution of the most effective and advanced resources used to fight the disease. 75% of anticancer drugs are consumed in Europe, North America and Japan, while as many as 30 other countries in the world do not even have a single radiotherapy device.

TAVI is here to stay and should be applied to a wider audience

Prof. Francesco Romeo
Head, Dept. of Cardiology and Interventional Cardiology
Policlinico Tor Vergata, Rome

The recent European Society of Cardiology (ESC) congress, held in Rome, specified the role of TAVI (percutaneous aortic valve replacement) in the treatment of degenerative aortic stenosis. Currently almost all percutaneous interventions are performed on inoperable patients by cardiac surgeons. According to Prof. Romeo, the enormous know-how accumulated over the years by interventional cardiologists allows them to envisage extending TAVI to categories of patients with minor contraindications to surgery.

Tissue Engineering and Cellular Replacement in Diabetes Treatment

Prof. Camillo Ricordi
Head, Diabetes Research Institute, Miami
Distinguished Professor of Medicine, University of Miami

Islet transplants offer similar results to those of other organ transplants in terms of long-term outcomes, although there is still a need for life-long assumption of anti-rejection drugs. New strategies for more effective diabetes treatments focus on engineering a mini-endocrine pancreas in the abdominal cavity, using 3D scaffolds and local protective systems, in order to avoid systemic anti-rejection drugs.

highlights

focus events

EMAS 2017 IN AMSTERDAM

The main goal of the Congress was to enable strategies for healthy aging. This requires a holistic multidisciplinary approach

12,000 CARDIOLOGISTS FROM ALL OVER THE WORLD

Euro PCR proves to be the most important event in the field of interventional cardiology

OVERVIEW OF EAU2017

Among the most discussed topics were prostate cancer, urinary incontinence, infertility and sexual disfunctions

ECCO - EUROPEAN CANCER CONGRESS 2017 IN AMSTERDAM

According to most oncologists, ECCO is the only truly multidisciplinary oncoloy congress in Europe

THE CHALLENGES OF EUROPEAN CARDIOLOGY IN ROME

30,000 cardiologists focus on reducing the impact of cardiovascular disease in the world

A WORLDWIDE UPDATE ON DIABETES & NEW TECHNOLOGIES

The major international event in the field of diabetes tratment with the participation of the world key leaders

2016 EFIC Congress in Dubrovnik

IBSA Symposium addressed novel GAGs formulations against osteoarthritis. 9 videos. Click here

...

Recordati update program at ESC 2016 in Rome

Four in-depth events at the Recordati booth: full video recording. 16 videos. Click here

...

Sigma-tau HealthScience Symposium in Helsinki

During the ESHRE 2016 annual meeting, the symposium focused on the role of metabolic and bioactive nutrients in infertility and sexual disfunctions. 23 videos. Click here

...

ISGE 2016 in Florence

Debate session devoted to the role of the mitochondria in oocyte quality and successful pregnancy. 8 videos. Click here

...

Prague, 11th Congress of the EuropeanSociety of Gynecology

Preis School Academy organized a plenary session on the role of progesterone in pregnancy. 11 videos. Click here

...

13-ICML in Lugano

4000 participants at the top world event on lymphoid neoplasms. 9 videos. Click here

...

From the 11th Congress of the European Society of Gynecology

The Symposium, sponsored by Endoceutics, focused on DHEA local treatment of VVA and dispareunia. 12 videos. Click here

Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK